Introduction {#s1}
============

Variations in the balance of the coronary arteries are common, particularly with regard to the supply of the posterior aspect of the left ventricle. In the majority of patients, the right coronary artery (RCA) reaches the crux of the heart and supplies the posterior descending artery (PDA) [@pone.0072672-Gorlin1]. Left-dominant (LD) anatomy, described as a variant of normal anatomy, has a prevalence of approximately 5--12% in the general population [@pone.0072672-Bazzocchi1]--[@pone.0072672-VasheghaniFarahani1]. In these individuals, the left circumflex artery (LCX) reaches the crux and supplies the posterior descending and, usually, the atrioventricular nodal branches [@pone.0072672-Bazzocchi1].

LD anatomy is believed to be associated with worse prognoses for patients with acute coronary syndrome (ACS) and stable coronary artery disease [@pone.0072672-Goldberg1], [@pone.0072672-Veltman1]. The PDA, arising from the RCA, may serve as a back-up supply in normal anatomy, with the right-dominant (RD) system acting in an overall protective manner. LD patients, in contrast, usually have only the left coronary artery to supply the majority of the myocardium. Thus, an event in a major vessel may, therefore, lead to a worse outcome. Furthermore, technical challenges exist in interventions associated with the LCX artery because of the steepness of its take-off, relative to other arteries [@pone.0072672-Goto1]. However, data describing the effects of coronary dominance in modern percutaneous coronary intervention (PCI) are scarce.

Methods {#s2}
=======

Study Design {#s2a}
------------

The Japan Cardiovascular Database (JCD) is a large, ongoing, prospective, multicenter, cohort study designed to collect clinical background and outcome data on PCI patients. Data pertaining to approximately 150 variables are being collected. In this registry, participating hospitals have been instructed to record data from hospital visits for consecutive PCI patients and to register these data into an internet-based database. The database system performs checks to ensure that the reported data are complete and internally consistent. PCIs performed using any commercially available coronary device may be included. The decision to perform PCI is made according to the attending physicians' clinical assessments of the patient. The study does not mandate specific interventional or surgical techniques, such as vascular access, or the use of a specific stent or closure device.

The majority of the clinical variables in the JCD were defined according to the National Cardiovascular Data Registry (NCDR), sponsored by the American College of Cardiology, to conduct comparative research and determine the factors that lead to disparities in PCI management. NCDR is a large PCI registry system with over 1,000,000 entries of ischemic heart disease and over 500,000 PCI entries collected from more than 500 institutions in the USA [@pone.0072672-Roe1], [@pone.0072672-Anderson1].

Cardiogenic shock was defined as a sustained (\>30 minutes) episode of systolic blood pressure \<90 mm Hg, and/or a cardiac index of \<2.2 L/min/m^2^ determined to be secondary to cardiac dysfunction, and/or the requirement for parenteral inotropic or vasopressor agents or mechanical support (e.g., intra-aortic balloon pump \[IABP\], extracorporeal circulation, ventricular assist devices) to maintain blood pressure and a cardiac index above the levels specified. Heart failure was defined as physician documentation or reported clinical symptoms of heart failure, such as unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention; or the description of rales, jugular venous distension, or pulmonary edema on physical examination; or pulmonary edema evident in chest radiographs and presumed to be associated with cardiac dysfunction. A low ejection fraction, without clinical evidence of heart failure, did not qualify as heart failure. Cardiopulmonary arrest was defined as cardiac arrest and/or respiratory arrest before the PCI procedure.

PCI for urgent therapy was defined as a procedure performed on an inpatient basis because of significant concerns regarding a risk of ischemia, infarction, and/or death. However, urgent PCI was also performed on outpatients or emergency department patients when a cardiac catheterization was required and warranted an admission, based on the clinical presentation. PCI for emergent therapy was defined as a procedure that is performed as soon as possible because of substantial concerns that ongoing ischemia and/or infarction could lead to death. The phrase "as soon as possible" referred to a situation wherein a patient has a clinical presentation of sufficient gravity that a scheduled case would be canceled to perform this procedure. PCI for salvage therapy was defined as a procedure that was performed as a last resort; in such cases, the patient was in cardiogenic shock at the start of the procedure or within the 10 minutes prior to the start of the procedure, and the patient had also received chest compressions for a total of at least 60 s or had been on unanticipated extracorporeal circulatory support (e.g., extracorporeal membrane oxygenation, cardiopulmonary support).

Information Disclosure {#s2b}
----------------------

Before the launch of the JCD, information on the objectives of the study, its social significance, and an abstract were provided to register this clinical trial with the University Hospital Medical Information Network. This Network is recognized by the International Committee of Medical Journal Editors as an "acceptable registry," according to a statement issued in September 2004 (UMIN R000005598).

JCD Participants {#s2c}
----------------

Major teaching hospitals within the metropolitan Tokyo area were selected for the pilot phase of this study, and the study protocol was approved by the institutional review board (IRB) committee at each site. In this registry, the data were collected since September 2008 from the 14 Japanese hospitals participating in the Japanese Cardiovascular Database (JCD) [@pone.0072672-Mogi1]--[@pone.0072672-Numasawa2]. All patients aged \>18 years undergoing PCI or an acetylcholine challenge test in these hospitals were enrolled.

Procedures and Data Collection {#s2d}
------------------------------

In this study, all ACS patients who underwent PCI were included. We did not include those who underwent acetylcholine challenge tests in our analysis since, typically, patients undergo this challenge test only if they do not have obstructive lesions and vasospastic angina is suspected [@pone.0072672-Ong1], [@pone.0072672-Ong2].

Data were analyzed from the 4873 patients undergoing PCI for ACS at one of the 14 Japanese hospitals participating in the JCD-Keio Interhospital Cardiology Study (KICS) between September 2008 and April 2013.

ACS is used to describe ST-elevation myocardial infarction (STEMI), non ST-elevation myocardial infarction (NSTEMI), and unstable angina (UA). STEMI was defined as myocardial infarction with ST elevation. These elements are equivalent to the definitions provided in the associated guidelines [@pone.0072672-Roe1], [@pone.0072672-Anderson1], [@pone.0072672-Anderson2]. When anterior lead-ST depression was documented as 'STEMI equivalent' by the attending cardiologist, they were also coded as STEMI. On the other hand, if there was no written documentation of STEMI in cases of V1--3 ST depression, those cases were coded NSTEMI.

Patients included in the study were divided into 2 groups, based on a diagnostic coronary angiogram performed prior to their PCI; patients with right- or co-dominant anatomies were placed into the RD group and those with left-dominant anatomies were included in the LD group. RD and co-dominant patients were placed into the same group because these patients have been demonstrated to have similar prognoses [@pone.0072672-Goldberg1]. Moreover, the hypothesis that PDAs, arising from the right coronary artery, may serve as a back-up blood supply in individuals with normal anatomy, would indicate that individuals with a co-dominant anatomy would be expected to derive similar benefits to those with RD anatomy. LD anatomy was defined as one in which the PDA originated from the LCX. RD anatomy was defined as the PDA originating from the RCA. Co-dominant anatomy was defined when only the PDA originated from the RCA and the RCA did not give rise to posterolateral branches, in combination with a large posterolateral branch originating from the LCX reaching near the posterior interventricular groove [@pone.0072672-Veltman1]. The dominance of each patient was documented by the treating cardiologist and failure to document dominance information was detected by the clinical coordinator and its input was mandated by the site data manager.

This research was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (KAKENHI No. 21790751). The JCD Steering Committee was responsible for overall study guidance, including the study protocol, data analyses, and interpretation of results. The Department of Healthcare Quality Assessment at Tokyo University independently managed the database. The KICS Committee managed the participating sites and provided monthly on-site monitoring services to assure data accuracy and completeness throughout the study. During the planning, implementation, and reporting of this study, there were no issues such as conflicts of interest, conflicts of responsibility, or intellectual property right concerns.

The study endpoints included in-hospital mortality, heart failure, cardiogenic shock, and other complications. Complications were defined as all complications, including severe dissection or coronary perforation, myocardial infarction after PCI, contrast-induced nephritis, cardiogenic shock or heart failure, cerebral bleeding or stroke, and bleeding complications. Bleeding complications in this registry were defined as those requiring transfusion, prolonging hospital stay, and/or causing a decrease in hemoglobin of \>3.0 g/dL [@pone.0072672-Mehta1]. Further, bleeding complications were subdivided into puncture-site bleeding, retroperitoneal bleeding, gastrointestinal bleeding, genitourinary bleeding, or other bleeding.

Data Analyses {#s2e}
-------------

Continuous variables are expressed as means and standard deviations (SD); categorical variables are expressed as percentages. Continuous variables were compared using Student's *t*-test, and differences between categorical variables were examined using a chi-squared test. A multiple logistic regression analysis was performed to determine the independent predictors of in-hospital mortality. Factors, at admission, that were evaluated in the multivariate model were age, 70--79 years; age, ≥80 years; body mass index (BMI) ≥ 30; presence of chronic kidney disease stage ≥ 3; presence of chronic obstructive pulmonary disease; presence of Canadian Cardiovascular Society class 4 angina; dialysis dependence; presence of heart failure; cardiogenic shock; cardiopulmonary arrest; left main trunk stenosis; STEMI; NSTEMI; PCI for emergent therapy; PCI for salvage therapy; and LD anatomy. All statistical calculations and analyses were performed using SPSS version 15 (SPSS, Chicago, IL, USA). *P*-values of \<0.05 were considered statistically significant.

Results {#s3}
=======

A total of 4873 ACS patients undergoing PCI were assessed. The average age of the patients was 67.6±11.8 years and 1081 (22.2%) patients were female. The numbers of STEMI, NSTEMI, and UA patients were 2334 (47.9%), 778 (16.0%), and 1761 (36.1%), respectively. The LD group was comprised of 464 patients (9.5%), and there were 4409 patients (90.5%) in the RD group. Among 4873 ACS patients, 639 (12.4%) had co-dominant anatomy.

Baseline Characteristics {#s3a}
------------------------

The baseline clinical characteristics of the 4873 patients in both groups are summarized in [Table 1](#pone-0072672-t001){ref-type="table"}. There were no major differences in the coronary risk factors, BMI, comorbidities (cerebrovascular disease, chronic obstructive pulmonary disease, presence of chronic kidney disease stage ≥3, hemodialysis, peripheral artery disease), or past history (prior myocardial infarction, prior heart failure, prior PCI, prior coronary artery bypass grafting). The numbers of patients presenting with symptoms of heart failure, cardiogenic shock, or cardiopulmonary arrest were significantly higher in the LD group than in the RD group (heart failure: 650 RD patients \[14.7%\] vs. 87 LD patients \[18.8%\], *P* = 0.025; cardiogenic shock: 322 RD patients \[7.3%\] vs. 48 LD patients \[10.3%\], *P* = 0.021; and cardiopulmonary arrest: 197 RD patients \[4.5%\] vs. 36 LD patients \[7.8%\], *P* = 0.003) ([Table 1](#pone-0072672-t001){ref-type="table"}).

10.1371/journal.pone.0072672.t001

###### Baseline clinical characteristics of each group.

![](pone.0072672.t001){#pone-0072672-t001-1}

                           RD+Co %(n = 4409)   LD %(n = 464)   *P* Value
  ----------------------- ------------------- --------------- -----------
  Age ≥80 years               16.2 (714)         18.3 (85)       0.236
  Age 70--79 years            32.3 (1422)       32.8 (152)       0.835
  Female                      22.4 (989)         19.8 (92)       0.217
  BMI ≥30                      5.4 (240)         4.7 (22)        0.589
  Coronary risk factors                                       
  DM                          37.2 (1642)       37.7 (175)       0.840
  DM with insulin              6.7 (297)         8.4 (39)        0.178
  Hypertension                70.1 (3089)       69.0 (320)       0.632
  Hyperlipidemia              61.2 (2699)       58.6 (272)       0.293
  Smoking                     39.2 (1730)       41.8 (194)       0.294
  Comorbidities                                               
  CVD                          8.5 (375)         9.3 (43)        0.601
  COPD                         2.7 (120)         4.3 (20)        0.057
  CKD stage ≥ 3               17.5 (770)         18.5 (86)       0.564
  Hemodialysis                 3.8 (166)         2.8 (13)        0.363
  PAD                          5.6 (248)         6.3 (29)        0.598
  History                                                     
  Prior MI                    16.3 (718)         15.1 (70)       0.551
  Prior HF                     6.5 (286)         7.1 (33)        0.621
  Prior PCI                   20.6 (910)         19.6 (91)       0.629
  Prior CABG                   4.1 (179)         2.4 (11)        0.077
  Presenting status                                           
  CCS class 4 angina          15.4 (681)         16.6 (77)       0.501
  HF                          14.7 (650)         18.8 (87)       0.025
  NYHA class 3/4               9.7 (426)         15.3 (71)      \<0.001
  Cardiogenic shock            7.3 (322)         10.3 (48)       0.021
  CPA                          4.5 (197)         7.8 (36)        0.003

RD, right dominant; Co, co-dominant; LD, left dominant; BMI, body mass index; DM, diabetes mellitus; CVD, cerebrovascular disease; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; PAD, peripheral artery disease; MI, myocardial infarction; HF, heart failure; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; CCS, Canadian Cardiovascular Society; NYHA, New York Heart Association; CPA, cardiac pulmonary arrest.

Angiographical Data and Procedural Information {#s3b}
----------------------------------------------

The angiographical and procedural data are listed in [Table 2](#pone-0072672-t002){ref-type="table"}. The number of patients with STEMI, NSTEMI, and UA were similar between the groups. There were no statistically significant differences in the proportions of drug eluting stents implanted (2387 RD patients \[54.1%\] vs. 259 LD patients \[55.8%\], *P* = 0.493), nor in the proportions of bare metal stents implanted (1493 RD patients \[33.9%\] vs. 143 LD patients \[30.8%\], *P* = 0.197).

10.1371/journal.pone.0072672.t002

###### Procedural information for each group.

![](pone.0072672.t002){#pone-0072672-t002-2}

                         RD+Co %(n = 4409)   LD %(n = 464)   *P* Value
  --------------------- ------------------- --------------- -----------
  Coronary status                                           
  STEMI                     48.2 (2125)       45.0 (209)       0.204
  NSTEMI                    15.7 (692)         18.5 (86)       0.125
  UA                        36.1 (1592)       36.4 (169)       0.919
  2-Vessel disease          42.9 (1890)       46.1 (214)       0.184
  3-Vessel disease          24.7 (1088)       22.2 (103)       0.256
  LMT stenosis               9.3 (410)         6.9 (32)        0.089
  PCI indication                                            
  Emergent therapy          48.3 (2129)       49.1 (228)       0.733
  Salvage therapy            3.5 (154)         6.7 (31)        0.002
  Stent Implantation                                        
  DES                       54.1 (2387)       55.8 (259)       0.493
  BMS                       33.9 (1493)       30.8 (143)       0.197
  Balloon angioplasty        7.1 (314)         8.4 (39)        0.301
  Puncture site                                             
  Radial artery             23.9 (1053)       22.0 (102)       0.389
  Femoral artery            74.2 (3273)       76.7 (356)       0.263
  IABP insertion                                            
  Before PCI                 2.9 (126)         2.8 (13)        0.945
  During/after PCI          10.2 (449)         13.8 (64)       0.016

RD, right dominant; Co, co-dominant; LD, left dominant; STEMI, ST elevation myocardial infarction; NSTEMI, non-ST elevation myocardial infarction; UA, unstable angina; LMT, left main trunk; PCI, percutaneous coronary intervention; DES, drug eluting stent; BMS, bare metal stent; IABP, intra-aortic balloon pump.

The proportions of IABPs used were analyzed in both groups. The numbers of IABP insertions before PCI procedures were similar in both groups (126 RD patients \[2.9%\] vs. 13 LD patients \[2.8%\], *P* = 0.945). However, the number of IABP insertions during and after PCI procedures was significantly higher in the LD group than in the RD group (449 RD patients \[10.2%\] vs. 64 LD patients \[13.8%\], *P* = 0.016).

In-hospital Outcomes/Complications {#s3c}
----------------------------------

[Table 3](#pone-0072672-t003){ref-type="table"} shows the overall in-hospital outcomes and complications for the 2 groups of patients. The in-hospital mortality rate was significantly higher in the LD group compared to the RD group (182 RD patients \[4.1%\] vs. 36 LD patients \[7.8%\], *P* = 0.001) ([Table 3](#pone-0072672-t003){ref-type="table"}). The combined rates of heart failure, cardiogenic shock, and death were also significantly higher in the LD group than in the RD group (349 RD patients \[7.9%\] vs. 53 LD patients \[11.4%\], *P* = 0.013). As listed in [Table 3](#pone-0072672-t003){ref-type="table"}, the rates of thrombolysis in myocardial infarction (TIMI) flow that were\<grade 3, the rates of hemoglobin decreases of \>3 g/dL, the rates of contrast-induced nephritis, and the rates of other complications, including bleeding complications, were similar for the 2 groups. Only gastrointestinal bleeding complications were significantly different between the groups (28 RD patients \[0.6%\] vs. 7 LD patients \[1.5%\], *P* = 0.044).

10.1371/journal.pone.0072672.t003

###### In-hospital outcome/complications in each group.
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                            RD+Co % (n = 4409)   LD % (n = 464)   *P* Value
  ------------------------ -------------------- ---------------- -----------
  All-cause death               4.1 (182)           7.8 (36)        0.001
  HF/shock/death                7.9 (349)          11.4 (53)        0.013
  TIMI flow grade \<3           6.2 (273)           6.7 (31)        0.686
  HB, \>3 g/dL decrease         14.0 (555)         13.7 (57)        0.941
  CIN                           19.6 (864)         87 (18.8)        0.712
  Any complications             13.6 (600)         15.1 (70)        0.395
  Dissection                     1.5 (52)           1.1 (5)         1.000
  Perforation                    0.7 (33)           0.9 (4)         0.776
  MI                             2.1 (92)           2.4 (11)        0.613
  HF                            3.3 (146)           4.5 (21)        0.179
  Shock                         3.2 (142)           3.9 (18)        0.413
  Dialysis                       1.8 (79)           0.9 (4)         0.184
  Stroke                         0.7 (31)           0.4 (2)         0.765
  ICH                            0.1 (4)            0.0 (0)         1.000
  Transfusion                   3.7 (161)           4.3 (20)        0.440
  Bleeding                      4.1 (179)           5.8 (27)        0.088
  Puncture site bleeding         1.4 (61)           2.4 (11)        0.103
  Hematoma                       1.0 (43)           0.6 (3)         0.620
  Retroperitoneal                0.1 (4)            0.2 (1)         0.394
  Gastrointestinal               0.6 (28)           1.5 (7)         0.044
  Genitourinary                  0.3 (12)           0.6 (3)         0.166
  Other                          1.5 (68)           1.7 (8)         0.694

RD, right dominant; Co, co-dominant; LD, left dominant; TIMI, thrombolysis in myocardial infarction; HF, heart failure; Hb, hemoglobin; CIN, contrast induced nephritis; MI, myocardial infarction; ICH, intracranial hemorrhage.

Multivariate logistic regression analysis showed that LD anatomy was one of the independent predictors for in-hospital mortality (odds ratio, 1.75; 95% confidence interval, 1.06--2.89; *P = *0.030). Cardiogenic shock, heart failure, and cardiopulmonary arrest were also independent predictors for in-hospital mortality ([Table 4](#pone-0072672-t004){ref-type="table"}).

10.1371/journal.pone.0072672.t004

###### Multivariate logistic regression analysis on in-hospital mortality.
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                         OR      95% CI     *P* Value
  -------------------- ------ ------------ -----------
  Left dominance        1.75   1.06--2.89     0.030
  Age, ≥80              3.64   2.40--5.53    \<0.001
  Age 70--79            1.61   1.08--2.41     0.02
  BMI ≥30               2.23   1.20--4.46     0.023
  CKD stage ≥3          3.48   2.33--5.20    \<0.001
  CCS class 4 angina    2.11   1.12--3.99     0.021
  STEMI                 4.59   2.16--9.74    \<0.001
  NSTEMI                3.58   1.68--7.65     0.001
  Cardiogenic shock     2.79   1.69--4.61    \<0.001
  HF                    2.54   1.73--3.71    \<0.001
  CPA                   2.42   1.21--4.85     0.012
  LMT stenosis          1.85   1.15--2.97     0.011

OR, odds ratio; CI, confidence interval; BMI, body mass index; CKD, chronic kidney disease; CCS, Canadian Cardiovascular Society; STEMI, ST elevation myocardial infarction; NSTEMI, non-ST elevation myocardial infarction; HF, heart failure; CPA, cardiac pulmonary arrest; LMT, left main trunk.

In-hospital Outcomes in Selected Subgroups {#s3d}
------------------------------------------

[Tables 5](#pone-0072672-t005){ref-type="table"} and [6](#pone-0072672-t006){ref-type="table"} show the results from the data analysis conducted in selected subgroups of high-risk patients. LD patients tended to have higher rates of in-hospital mortality for patients with cardiogenic shock and/or cardiopulmonary arrest (101 RD patients \[27.2%\] vs. 21 LD patients \[38.9%\], *P* = 0.106) ([Table 5](#pone-0072672-t005){ref-type="table"}), or left main trunk stenosis (44 RD patients \[10.7%\] vs. 6 LD patients \[18.8%\], *P* = 0.239) ([Table 6](#pone-0072672-t006){ref-type="table"}).

10.1371/journal.pone.0072672.t005

###### In-hospital outcomes/complications in patients with cardiogenic shock and/or cardiopulmonary arrest.
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                         RD+Co % (n = 371)   LD % (n = 54)   *P* Value
  --------------------- ------------------- --------------- -----------
  All-cause death           27.2 (101)         38.9 (21)       0.106
  HF/shock/death            36.1 (134)         46.3 (25)       0.176
  TIMI flow grade \<3        14.6 (54)         13.0 (7)        1.000
  Bleeding                   12.1 (45)         24.1 (13)       0.031
  CIN                       31.8 (118)         33.3 (18)       0.876

RD, right dominant; Co, co-dominant; LD, left dominant; HF, heart failure; TIMI, thrombolysis in myocardial infarction; Hb, hemoglobin; CIN, contrast induced nephritis.

10.1371/journal.pone.0072672.t006

###### In-hospital outcomes/complications in patients with left main trunk stenosis.
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                         RD+Co % (n = 410)   LD % (n = 32)   *P* Value
  --------------------- ------------------- --------------- -----------
  All-cause death            10.7 (44)         18.8 (6)        0.239
  HF/shock/death             17.8 (73)         18.8 (6)        0.814
  TIMI flow grade \<3        9.0 (37)          12.5 (4)        0.523
  Bleeding                   7.8 (32)           3.1 (1)        0.496
  CIN                       26.1 (107)         15.6 (5)        0.213

RD, right dominant; Co, co-dominant; LD, left dominant; HF, heart failure; TIMI, thrombolysis in myocardial infarction; Hb, hemoglobin; CIN, contrast induced nephritis.

Discussion {#s4}
==========

The present study concluded that coronary dominance affected in-hospital outcomes. LD patients had significantly worse in-hospital outcomes compared with RD patients and LD anatomy was an independent predictor of in-hospital mortality in the multivariate analysis. The significance of coronary dominance should be taken into consideration when treating ACS patients with PCI. The absence of the protective effects of a double supply to the myocardium and technical challenges caused by the anatomy may be particularly important in these patients.

Previous studies also have shown that LD patients with coronary artery disease may have worse prognoses than RD patients with coronary artery disease. Goldberg et al. demonstrated that LD is a significant and independent predictor of increased long-term mortality in patients with ACS [@pone.0072672-Goldberg1]. However, in their study, the revascularization rate (by PCI or coronary artery bypass graft \[CABG\]) was approximately 60% and the number of patients with stent implantation was not reported. In the present study, PCI was attempted in all patients.

The higher in-hospital mortality associated with LD patients led to the hypothesis that the RCA serves as a back-up supply in patients with RD anatomy, providing a measure of protection for the myocardium in ACS patients. According to one study [@pone.0072672-Stribling1], patients with acute occlusion of the LCX, presenting with NSTEMI, had better outcomes than did those with STEMI. The analysis indicated that patients with RD anatomies were more likely to have NSTEMI. In concordance with our study, the authors asserted that RD may confer a protective effect in cases of acute occlusion of the LCX, minimizing the infarct size. The data also revealed that smaller infarct sizes and higher likelihoods of RD were associated with NSTEMI patients, supporting their conclusion.

In general, a dominant LCX has several acute angles in its course, including at its origin and at its distal end where it becomes the PDA. These acute angles lead to turbulence and shear stress during blood flow that, in turn, may enhance thrombus formation and platelet activity [@pone.0072672-Yu1], [@pone.0072672-Smith1]. The acute angles, and resultant turbulence and shear stress, also contribute to the difficulty of LCX interventions. Yip et al. concluded that LD is related to unsuccessful reperfusion and to a higher 30-day mortality rate in LCX infarct-related acute myocardial infarction (MI) patients [@pone.0072672-Yip1]. In addition, Auriti et al. showed that coronary flow reserve was more impaired in LCX than LAD just after Y-graft intervention, which was a graft formed by the left internal mammary artery (LIMA) connected to the LAD and by a free right internal mammary artery (RIMA) connected to LIMA and a marginal artery of the LCX [@pone.0072672-Auriti1]. Clinically, a recent study showed that the 30-day prognostic outcome was less favorable in LCX-related acute inferior MI compared to RCA-related acute inferior MI [@pone.0072672-Chen1]. The reasons for this difference were suggested to include higher peak levels of creatine kinase-MB isoenzyme, lower left ventricular ejection fractions, and the higher numbers of advanced congestive heart failure that were observed in LCX-related acute inferior MIs. Lower rates of stent implantation and collateral circulation might also contribute to the worse outcomes. The study data did not indicate the manner in which dominance might affect mortality; Kim concluded patients with an occluded LCX presented with less ST elevation and primary PCI [@pone.0072672-Kim1]. Multivariate analysis showed that primary PCI decreased the hospital mortality for patients with occluded coronary arteries. For these reasons, we suspect that more flow disturbances are induced, leading to more adverse effects on hemodynamics during PCI, in patients with PCI of a dominant LCX.

Larger infarct size is another reason affecting in-hospital mortality for LD patients. IABPs might be effective for limiting infarct sizes in such cases. Pierrakos et al. showed that during reperfusion, IABPs increased coronary blood flow, and effectively limited infarct size [@pone.0072672-Pierrakos1]. Our study showed that the proportion of IABP insertions during and after PCI procedures was significantly higher in the LD group than in the RD group. We suspect that the LD group tended to have hemodynamic instability more frequently than the RD group during the procedure because of the single coronary supply. Moreover, to overcome the difficulty for intervening LD LCX arteries with PCI, CABG would be considered. However, further prospective study will be necessary.

Study Limitations {#s4a}
-----------------

Several limitations may exist in this study. First, this study was an analysis of a multicenter cohort study rather than an observational, non-randomized trial. Second, the study population was of limited size, compared to the number of sites included in our registry. Third, we did not analyze whether the target vessel lesions compromised PDA function. Lastly, all candidates underwent PCI procedures. Some patients with critical conditions, such as cardiogenic shock or left main trunk stenosis, are more favorable candidates for CABG than for PCI and these patients, who underwent CABG instead of PCI, were excluded. Therefore, we do not have data indicating which treatment was better for these patients.

Conclusions {#s4b}
-----------

LD patients had higher in-hospital mortality compared with RD patients in a population with ACS patients; LD anatomy was an independent predictor for in-hospital mortality in the multivariate analysis in this Japanese, real-world, multicenter study. A single coronary supply, typical of patients with an LD anatomy, should be recognized as a high-risk feature.
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